SI1684715T1 - Sestavki, ki obsegajo nerameksan - Google Patents
Sestavki, ki obsegajo nerameksanInfo
- Publication number
- SI1684715T1 SI1684715T1 SI200431683T SI200431683T SI1684715T1 SI 1684715 T1 SI1684715 T1 SI 1684715T1 SI 200431683 T SI200431683 T SI 200431683T SI 200431683 T SI200431683 T SI 200431683T SI 1684715 T1 SI1684715 T1 SI 1684715T1
- Authority
- SI
- Slovenia
- Prior art keywords
- neramexane
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51798103P | 2003-11-05 | 2003-11-05 | |
EP04810445A EP1684715B1 (en) | 2003-11-05 | 2004-11-05 | Compositions comprising neramexane |
PCT/US2004/037026 WO2005044228A2 (en) | 2003-11-05 | 2004-11-05 | Compositions comprising cyclohexylamines and aminoadamantanes |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1684715T1 true SI1684715T1 (sl) | 2011-07-29 |
Family
ID=34572981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200431683T SI1684715T1 (sl) | 2003-11-05 | 2004-11-05 | Sestavki, ki obsegajo nerameksan |
Country Status (19)
Country | Link |
---|---|
US (4) | US20070270500A1 (sl) |
EP (2) | EP1684715B1 (sl) |
AR (1) | AR046314A1 (sl) |
AT (1) | ATE504290T1 (sl) |
AU (1) | AU2004287489B9 (sl) |
CA (1) | CA2543865C (sl) |
CL (1) | CL2008000125A1 (sl) |
CY (1) | CY1111456T1 (sl) |
DE (1) | DE602004032164D1 (sl) |
DK (1) | DK1684715T3 (sl) |
ES (2) | ES2362581T3 (sl) |
HR (1) | HRP20110482T1 (sl) |
IL (1) | IL175623A (sl) |
PL (1) | PL1684715T3 (sl) |
PT (1) | PT1684715E (sl) |
SI (1) | SI1684715T1 (sl) |
TW (1) | TWI350750B (sl) |
WO (1) | WO2005044228A2 (sl) |
ZA (1) | ZA200603561B (sl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2483126T3 (es) * | 2004-06-17 | 2014-08-05 | Merz Pharma Gmbh & Co. Kgaa | Formulaciones de formas de dosificación de neramexano |
US20060002999A1 (en) | 2004-06-17 | 2006-01-05 | Forest Laboratories, Inc. | Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
US20070060887A1 (en) * | 2005-08-22 | 2007-03-15 | Marsh David A | Ophthalmic injector |
TW200916091A (en) * | 2007-06-08 | 2009-04-16 | Merz Pharma Gmbh & Amp Co Kgaa | Neramexane for the treatment of nystagmus |
EP2548552B1 (en) | 2007-09-12 | 2015-11-18 | Merz Pharma GmbH & Co. KGaA | Titration package for 1-amino-alkylcyclohexanes |
TW201006463A (en) * | 2008-06-26 | 2010-02-16 | Merz Pharma Gmbh & Co Kgaa | Pharmaceutical compositions comprising aminocyclohexane derivatives |
TWI432188B (zh) | 2008-12-19 | 2014-04-01 | Merz Pharma Gmbh & Co Kgaa | 供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類 |
EP2373304B1 (en) | 2008-12-19 | 2014-07-30 | Merz Pharma GmbH & Co. KGaA | Neramexane for the treatment of mast cell mediated diseases |
EP2582356A1 (en) | 2010-06-18 | 2013-04-24 | Merz Pharma GmbH & Co. KGaA | Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES413944A1 (es) | 1972-04-20 | 1976-06-01 | Merz & Co | Procedimiento para la preparacion de compuestos de adamen- tano trisustituidos en las posiciones 1,3,5. |
DE2856393C2 (de) | 1978-12-27 | 1983-04-28 | Merz + Co GmbH & Co, 6000 Frankfurt | Arzneimittel zur Behandlung von Morbus Parkinson |
US5506231A (en) | 1989-03-31 | 1996-04-09 | The Children's Medical Center Corporation | Treatment of aids dementia, myelopathy and blindness |
US5334618A (en) | 1991-04-04 | 1994-08-02 | The Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
DE58905637D1 (de) | 1989-04-14 | 1993-10-21 | Merz & Co Gmbh & Co | Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie. |
US5614560A (en) | 1991-04-04 | 1997-03-25 | Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
US5455279A (en) | 1991-04-19 | 1995-10-03 | The Children's Medical Center Corporation | Regimen method of mediating neuronal damage using nitroglycerine |
WO1992018112A1 (en) | 1991-04-19 | 1992-10-29 | The Children's Medical Center Corporation | Method of preventing nmda receptor complex-mediated neuronal damage |
EA002254B1 (ru) | 1997-06-30 | 2002-02-28 | Мерц + Ко. Гмбх Унд Ко. | 1-аминоалкилциклогексановые антагонисты рецепторов nmda |
US6071966A (en) * | 1997-06-30 | 2000-06-06 | Merz + Co. Gmbh & Co. | 1-amino-alkylcyclohexane NMDA receptor antagonists |
SE9901077D0 (sv) | 1999-03-23 | 1999-03-23 | Astra Ab | Novel use |
US6444702B1 (en) | 2000-02-22 | 2002-09-03 | Neuromolecular, Inc. | Aminoadamantane derivatives as therapeutic agents |
TW593223B (en) * | 2000-06-20 | 2004-06-21 | Merz Pharma Gmbh & Co Kgaa | 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
MXPA03005130A (es) * | 2000-12-07 | 2004-12-06 | Neuromolecular Inc | Metodos para tratar trastornos neurosiquiatricos con antagonistas del receptor del nmda. |
US6828462B2 (en) * | 2001-11-07 | 2004-12-07 | Merz Pharma Gmbh & Co. Kgaa | Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
TW200410672A (en) * | 2002-07-19 | 2004-07-01 | Merz Pharma Gmbh & Co Kgaa | NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau |
MXPA05012493A (es) * | 2003-05-27 | 2006-05-25 | Forest Laboratories | Combinacion de un antagonista del receptor de nmda y un inhibidor selectivo de reabsorcion de serotonina para el tratamiento de depresion y otros trastornos de estado de animo. |
-
2004
- 2004-11-01 AR ARP040104007A patent/AR046314A1/es not_active Application Discontinuation
- 2004-11-05 ES ES04810445T patent/ES2362581T3/es active Active
- 2004-11-05 PL PL04810445T patent/PL1684715T3/pl unknown
- 2004-11-05 WO PCT/US2004/037026 patent/WO2005044228A2/en active Application Filing
- 2004-11-05 EP EP04810445A patent/EP1684715B1/en active Active
- 2004-11-05 SI SI200431683T patent/SI1684715T1/sl unknown
- 2004-11-05 ES ES10184394.4T patent/ES2507500T3/es active Active
- 2004-11-05 AT AT04810445T patent/ATE504290T1/de active
- 2004-11-05 AU AU2004287489A patent/AU2004287489B9/en not_active Ceased
- 2004-11-05 DK DK04810445.9T patent/DK1684715T3/da active
- 2004-11-05 CA CA2543865A patent/CA2543865C/en not_active Expired - Fee Related
- 2004-11-05 TW TW093133869A patent/TWI350750B/zh not_active IP Right Cessation
- 2004-11-05 DE DE602004032164T patent/DE602004032164D1/de active Active
- 2004-11-05 PT PT04810445T patent/PT1684715E/pt unknown
- 2004-11-05 US US10/578,765 patent/US20070270500A1/en not_active Abandoned
- 2004-11-05 EP EP10184394.4A patent/EP2289489B1/en active Active
-
2006
- 2006-05-04 ZA ZA200603561A patent/ZA200603561B/en unknown
- 2006-05-14 IL IL175623A patent/IL175623A/en not_active IP Right Cessation
-
2008
- 2008-01-16 CL CL200800125A patent/CL2008000125A1/es unknown
-
2009
- 2009-10-14 US US12/587,885 patent/US20100035995A1/en not_active Abandoned
-
2011
- 2011-05-09 CY CY20111100444T patent/CY1111456T1/el unknown
- 2011-06-29 HR HR20110482T patent/HRP20110482T1/hr unknown
-
2012
- 2012-04-26 US US13/456,751 patent/US20120238631A1/en not_active Abandoned
-
2014
- 2014-08-07 US US14/453,807 patent/US20140350114A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE602004032164D1 (de) | 2011-05-19 |
PT1684715E (pt) | 2011-05-02 |
HRP20110482T1 (hr) | 2011-07-31 |
IL175623A (en) | 2012-10-31 |
ZA200603561B (en) | 2007-07-25 |
AU2004287489B2 (en) | 2008-08-28 |
EP1684715A2 (en) | 2006-08-02 |
ES2507500T3 (es) | 2014-10-15 |
CA2543865A1 (en) | 2005-05-19 |
EP1684715B1 (en) | 2011-04-06 |
ES2362581T3 (es) | 2011-07-07 |
EP2289489A2 (en) | 2011-03-02 |
DK1684715T3 (da) | 2011-07-11 |
CA2543865C (en) | 2012-09-04 |
PL1684715T3 (pl) | 2011-09-30 |
ATE504290T1 (de) | 2011-04-15 |
WO2005044228A2 (en) | 2005-05-19 |
AR046314A1 (es) | 2005-11-30 |
TW200526195A (en) | 2005-08-16 |
EP2289489A3 (en) | 2012-06-06 |
AU2004287489B9 (en) | 2008-10-09 |
US20140350114A1 (en) | 2014-11-27 |
US20070270500A1 (en) | 2007-11-22 |
TWI350750B (en) | 2011-10-21 |
AU2004287489A1 (en) | 2005-05-19 |
CL2008000125A1 (es) | 2008-03-14 |
CY1111456T1 (el) | 2015-08-05 |
US20120238631A1 (en) | 2012-09-20 |
US20100035995A1 (en) | 2010-02-11 |
EP2289489B1 (en) | 2014-07-16 |
WO2005044228A3 (en) | 2006-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0301554D0 (en) | Immunostimulatory compositions | |
GB0305941D0 (en) | Composition | |
GB0319874D0 (en) | Novel formulation | |
GB0302738D0 (en) | Composition | |
GB0318448D0 (en) | Formulation | |
GB0329907D0 (en) | Compositions | |
EP1613352A4 (en) | MICRO-AGREED COMPOSITIONS | |
PL1684715T3 (pl) | Kompozycje zawierające nerameksan | |
GB0329597D0 (en) | Compositions | |
GB0312195D0 (en) | Formulation | |
GB0320522D0 (en) | Formulation | |
GB0300602D0 (en) | Compositions | |
GB0324574D0 (en) | Novel compositions | |
GB0303876D0 (en) | Formulation | |
GB0328023D0 (en) | Novel compositions | |
GB0309317D0 (en) | Composition | |
GB0316857D0 (en) | Compositions | |
GB0306312D0 (en) | Composition | |
GB0301869D0 (en) | Composition | |
GB0325537D0 (en) | Compositions | |
GB0326075D0 (en) | Compositions | |
GB0322118D0 (en) | Arthropodicdal compositions | |
GB0310479D0 (en) | Compositions | |
GB0310480D0 (en) | Compositions | |
GB0319649D0 (en) | Compositions |